GVE Ltd. (Headquarters: Chuo-ku, Tokyo, Representative Director CEO: Koji Fusa, hereinafter “GVE”) and CMIC Holdings (Headquarters: Minato-ku, Tokyo, Representative Director and CEO: Kazuo Nakamura, hereinafter “CMIC”) have partnered and conducted joint research with the aim of enabling the smooth movement of people across borders in the event that additional essential information is required, such as personal health data as called for during the recent Covid 19 pandemic.
Hence, GVE developed a concept for “a vaccine history passport” to meet legal immigration requisites. The technology underpinning this solution has successfully been patented by GVE and is now also adopted (September 9, 2024) by the World Health Organization in its WHO Digital Clearing House which assesses, curates, and catalogues digital health solutions that support primary health care (“PHC”) delivery (https://dch-test.who.int/search).
Development background
GVE’s global advisor, Professor Georg Holländer (University of Oxford) reasons that the digital recording of personal medical information requires highly secured protection. The current standards do not uniformly meet this essential condition for electronic medical records. In contrast, GVE’s radically novel private key infrastructure provides the necessary privacy protection unparalleled by other companies.
The ability to document and present up-to-date vaccination records constituted an important aspect of the public health efforts to control Covid-19 pandemic and will most likely be part of effective measures in future pandemics. In Japan, the Vaccine Record System (“VRS”) was created as a touchstone of the Digital Agency to facilitate collaborations between regional and national governmental agencies and to issues vaccination certificates for overseas travels. However, electronic and paper-based certificates differ considerably between individual countries and render pre-travel documentation and boarder immigration inspections time consuming, error prone, possibly incompatible with locally used software solutions. Moreover, these certificates are not infrequently subject to forgeries. Indeed, health certificates issued in Europe and the United States frequently use QR codes which are easily falsified and thus enable an illegal trade of fake health attestations.
There is hence an undeniable need for a universal digital system that is secure, automatically accredits the authenticity of health certificates and swiftly identifies falsifications. A secure system of documenting health certificates specifically and any additional relevant personal health records in general will smoothen safe cross-border travel, now and at times of future pandemics.
Proposal to WHO
In light of the growing concern of safe, secure and accurate medical data exchange, GVE teamed up with CMIC, Japan’s first contract research organization (“CRO”), to develop an advanced Vaccination Information Check System at Airports (designated VICSA) that manages effectively both passport and vaccination information. VICSA determines whether vaccination certificates are based on original medical documentation entered at the time of vaccination, thus rendering the creation of falsified or fabricated attestations impossible. Because VICSA links an individual’s vaccination history directly to that person’s passport details, the system is swiftly able to determine whether specific immigration entry requirements at the destination country are met prior to travel at the airport of origin and disembarkation, respectively.
A further compelling advantage of VICSA for immigration control is that travelers will not need to rely on the use of smartphones or specific apps to register and document their vaccination status, an inconvenience which carries additional risks for fraud.
Based on these outstanding technical and safety features as well as its superior utility, VICSA has now been included in the catalog of the WHO Digital Clearing House.
About Collaboration
GVE closely collaborated with CMIC to establish a comprehensive advancement of the VICSA platform. GVE is a world leader in creating technologies and infrastructures that employs real-time data sharing with unparalleled end-to-end security for the exchange of sensitive information.
CMIC is a well-recognized Japanese leader offering health care solutions nationally and internationally in support of companies and governments. Combining the proprietary know-how and expertise of GVE and CMIC, a solution for “vaccination passports” was created which allows countries that adopt VICSA to document and verify certificates in a secure, fast and confidential fashion superior to that of any other platform available to date.
GVE is pleased to respond to any queries regarding VICSA and its implementation: info@gve.net.
Further Developments
GVE develops digital solutions and integrated infrastructures for electronic medical records (EMR)based on and extending from the aforementioned VICSA technology. The platform will provide a unique resource for governments and a broad range stakeholders wishing to accurately store, and safely exchange digital health data in a secure and confidential way. GVE’s platform solution will promote the delivery of health care and enhance the precision and accuracy in health-related data storage and access in real time.
GVE notably also develops revolutionary digital solutions that overcome the acknowledged challenges, anticipated limitations and demonstrated restrictions of public key cryptography infrastructure (PKI) such as hidden costs, power consumption, space requirements, the need for dedicated round the clock IT support, and data security risks (including compliance Insurance Portability and Accountability Act (HIPAA), to name a few.
In addition, GVE also designs and provides original solutions for complex digital security infrastructures essential for countries wishing to harness the technology to transform how its people and businesses live, work and play.
Further Information
WHO Digital Clearing House Catalogue
https://dch-test.who.int/search
WHO Digital Clearing House Assessment Resutls
https://dch-test.who.int/search-solution/464bc445-7771-420c-a495-13ce4a80c000
GVE Ltd.
GVE Ltd was founded in 2017 and successfully developed the world’s first digital infrastructure providing an unrivaled solution to the recognized threat that even quantum computer-based security technologies are vulnerable to hacking. GVE succeeded in developing the world’s first real-time-gross settlement (RTGS) for all 8 billion individuals and over 300 million businesses for 200 different fiat currencies for both central banks and private sector financial institutions on a single platform at unprecedented levels of security, both in terms of confidentiality and of the integrity, and unmatched low costs.
Further information: https://gve.net/en/
CMIC Holdings
CMIC Holdings was founded in 1992 as Japan’s first clinical research organization (CRO) and ranks today among the largest in Japan. CMIC provides comprehensive support services for pharmaceutical, biotechnology, and medical device companies, conduct clinical trials and support drug development and manufacturing. CMIC Group employs over 7,000 employees in 25 branches around the world.
Further information: https://www.cmicgroup.com